↓ Skip to main content

A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia

Overview of attention for article published in BMC Complementary Medicine and Therapies, January 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
7 news outlets
twitter
16 X users
facebook
2 Facebook pages
video
1 YouTube creator

Readers on

mendeley
129 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia
Published in
BMC Complementary Medicine and Therapies, January 2019
DOI 10.1186/s12906-019-2430-y
Pubmed ID
Authors

Haridas Upadya, S. Prabhu, Aravinda Prasad, Deepa Subramanian, Swati Gupta, Ajay Goel

X Demographics

X Demographics

The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 129 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 129 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 15 12%
Student > Bachelor 15 12%
Researcher 13 10%
Other 10 8%
Student > Ph. D. Student 7 5%
Other 20 16%
Unknown 49 38%
Readers by discipline Count As %
Medicine and Dentistry 18 14%
Nursing and Health Professions 13 10%
Pharmacology, Toxicology and Pharmaceutical Science 12 9%
Biochemistry, Genetics and Molecular Biology 10 8%
Agricultural and Biological Sciences 6 5%
Other 12 9%
Unknown 58 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 72. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 February 2024.
All research outputs
#597,756
of 25,418,993 outputs
Outputs from BMC Complementary Medicine and Therapies
#78
of 3,963 outputs
Outputs of similar age
#13,836
of 446,632 outputs
Outputs of similar age from BMC Complementary Medicine and Therapies
#4
of 65 outputs
Altmetric has tracked 25,418,993 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,963 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,632 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 65 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.